Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has provided an announcement.
Shandong Weigao Group Medical Polymer Company Limited held its Annual General Meeting on 27 May 2025, where all proposed resolutions were successfully passed by poll. Key resolutions included the approval of the audited financial statements for 2024, the declaration of a final dividend, and the reappointment of Deloitte Touche Tohmatsu as the company’s auditor. The successful passing of these resolutions indicates strong shareholder support and positions the company for continued stability and growth.
The most recent analyst rating on (HK:1066) stock is a Buy with a HK$6.40 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical polymer industry, focusing on the production of medical devices and related products.
Average Trading Volume: 10,900,084
Technical Sentiment Signal: Hold
Current Market Cap: HK$25.87B
See more insights into 1066 stock on TipRanks’ Stock Analysis page.